Business Context and Reporting Period
This Form 8-K was filed by The RMR Group Inc. on June 23, 2016, regarding events occurring on that date. The filing addresses a significant change in corporate governance following the death of an Independent Director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial performance data.
Material Changes
On June 23, 2016, Mr. Frederick N. Zeytoonjian, an Independent Director, passed away. Mr. Zeytoonjian had served on the Board since November 23, 2015, and was a member of the Audit, Compensation, and Nominating and Governance Committees, as well as the Chair of the Compensation Committee.
His death reduced the Audit Committee membership to two, rendering the Company noncompliant with Nasdaq Rule 5605(c)(2), which requires a minimum of three members.
Outlook, Risks, and Management Commentary
The Company notified Nasdaq of the noncompliance and intends to cure the deficiency by identifying and appointing a new Independent Director to the Audit Committee prior to the expiration of the cure period. The cure period extends until the earlier of the next annual shareholders meeting or June 23, 2017. The Board expressed deep sadness regarding the loss and extended condolences to the family.
Investor Verification Checklist
- Confirm the timeline for the appointment of a new Independent Director to the Audit Committee.
- Verify the Company's continued compliance status with Nasdaq listing rules regarding committee composition.
- Monitor future filings for the announcement of the new director's appointment.